Isotretinoin and the risk of psychiatric disturbances: A global study shedding new light on a debatable story

43Citations
Citations of this article
42Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Introduction: Isotretinoin-related risk of depression and suicidal behavior is a topic of inconclusiveness. A crucial knowledge gap exists in defining the association of isotretinoin with other psychiatric comorbidities. Objective: To evaluate the risk of psychiatric outcomes among patients with acne treated with isotretinoin versus oral antibiotics. Methods: A global population-based retrospective cohort study enrolled 2 groups of patients with acne managed by isotretinoin (n = 75,708) and oral antibiotics (n = 75,708). Patients were compared regarding the risk of 9 psychiatric outcomes. Results: Relative to those treated with oral antibiotics, patients prescribed isotretinoin experienced lower risk of depression (hazard ratio [HR], 0.90; 95% confidence interval [CI], 0.87-0.93; P

Cite

CITATION STYLE

APA

Kridin, K., & Ludwig, R. J. (2023). Isotretinoin and the risk of psychiatric disturbances: A global study shedding new light on a debatable story. Journal of the American Academy of Dermatology, 88(2), 388–394. https://doi.org/10.1016/j.jaad.2022.10.031

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free